We will cover what the actual studies found when researchers measured semaglutide and tirzepatide in breast milk, what the FDA prescribing labels say, how molecular weight affects milk transfer, what risks remain theoretical versus proven, and what alternatives exist for mothers who want to lose weight without risking their milk supply
The delivery method is fundamentally flawed
Some findings are promising, particularly for symptoms tied to appetite and insulin resistance
Information We Collect We collect the following categories of information: Contact information you provide through inquiry forms or at checkout: name, email address, shipping address, telephone number, and institution or laboratory affiliation Order information including products purchased, lot numbers shipped, order dates, and amounts Payment information is collected and processed by our third-party payment processors
Different pools, different yardsticks, so dont read them as one figure, but the direction holds